In 2013 the National Eye Institute completed its landmark AREDS 2 study. This 5 year study showed that a revised formula can reduce the risk of progressing to advanced AMD by up to 18 percent, compared to the original AREDS formula.
Due to the results of the AREDS 2 study and positive feedback from thousands of doctors and their patients, Viteyes® is discontinuing its older formulas and transitioning to AREDS 2 based formulas.
Viteyes® AREDS 2 contains no beta-carotene, adds 10mg of lutein and 2mg of zeaxanthin and reduced zinc to 25 mg – a combination based on the latest extensive AREDS 2 findings. Your eye health is important to us, which is why we remain committed to offering you the best possible supplements. Compare Viteyes® AREDS 2 to Viteyes® AREDS Formula.